Purple Biotech Ltd (TLV:PPBT)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1.000
0.00 (0.00%)
At close: Feb 20, 2026
Market Cap18.58M -44.4%
Revenue (ttm)n/a
Net Income-10.76M
EPS-0.02
Shares Out1.86B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume290,000
Average Volume2,845,506
Open1.000
Previous Close1.000
Day's Range1.000 - 1.000
52-Week Range1.000 - 6.100
Beta-0.72
RSI40.99
Earnings DateFeb 6, 2026

About Purple Biotech

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin recept... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1968
Employees 9
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol PPBT
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements